Rhythm

Older heart failure patients ineligible for transplants fare well on novel pump, opening door to new treatment option

Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) — A common heart pump has traditionally been seen as only a short-term option for heart-failure patients but new research shows it may provide a similar quality of support as a permanent treatment in patients ineligible for transplantation. The study, part of the […]

The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science | ACCP/CSRC Position Paper

ASHBURN, Va., April 2, 2019 /PRNewswire/ — American College of Clinical Pharmacology® & Cardiac Safety Research Consortium  are pleased to announce the publication of their first co-authored paper, “The Potential Role of the J-Tpeak Interval in Pro-arrhythmic Cardiac Safety − Current State-of-the-Science from the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium,” in The […]

Hemovent Reports Successful in vivo Pilot Study of MOBYBOX™ by Minnesota Resuscitation Consortium (MRC), Which is Developing a ‘Super Ambulance’ Equipped to Advance Cardiac Arrest Treatment

MINNEAPOLIS & AACHEN, Germany–(BUSINESS WIRE)–Hemovent GmbH announced today that its next-generation ECMO (ExtraCorporeal Membrane Oxygenation) system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will be equipped with the latest technology to advance treatment of cardiac-arrest emergency patients. A ‘super […]

Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in LVAD Patients

NEW YORK and MELBOURNE, Australia, March 26, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the International Center for Health Outcomes and Innovation Research (InCHOIR) at the Icahn School of Medicine at Mount Sinai and Mesoblast have entered into […]

Bardy Diagnostics™ Selected as Winner of The Impact Pediatric Health Competition At SXSW 2019

SEATTLE, March 26, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the industry’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced it has been selected as one of four winners of the Impact […]

Foundational Publication Validates Acutus AcQMap System’s Breakthrough Non-Contact Technology

CARLSBAD, Calif., March 25, 2019 /PRNewswire/ — Acutus Medical today announced the publication of “High Resolution Non-Contact Charge Density Mapping of Endocardial Activation” in JCI Insight. This foundational manuscript indicates that charge mapping enables unmatched visualization of the conduction patterns and localized non-pulmonary vein (PV) therapeutic targets in patients with atrial arrhythmias, such as atrial […]

CardioFocus Announces European CE Mark Approval Of Breakthrough HeartLight® X3 System For The Treatment Of Atrial Fibrillation

MARLBOROUGH, Mass., March 25, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System. The HeartLight X3 System is a third generation technology building upon the advanced features of the HeartLight Endoscopic […]

Impulse Dynamics Receives FDA Approval for Breakthrough Optimizer® Smart System Delivering CCM™ Therapy for Treatment of Heart Failure

ORANGEBURG, New York, March 21, 2019 /PRNewswire/ — Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that it has received approval from the United States Food and Drug Administration for its first-in-class Optimizer Smart System (link to FDA announcement:  https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634103.htm). Designed to address a significant unmet […]

FDA approves new device for treating moderate to severe chronic heart failure in patients

SILVER SPRING, Md., March 21, 2019 /PRNewswire/ — The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat. […]

Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting

VANCOUVER, March 20, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of new Brinavess® (vernakalant hydrochloride, IV) data at the American College of Cardiology 2019 Annual Meeting taking place March 16-18, 2019, in New Orleans.  This poster presentation highlights reduced […]